glp gip glucagon & cagrilintide Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, has well-established weight-loss benefits. Cagrilintide, a long-acting analogue of the satiety hormone amylin, has shown promise for weight loss in early trials. The potential benefit Retatrutide + Cagrilintide: Quad-Pathway Stack

HUBERMAN: My whole purpose in doing this episode is to highlight how these different molecules ought to work, how they've been shown to work in animal models, and therefore how they might be working in humans

The name is marketing shorthand, not a medical descriptor

Gastrointestinal adverse effects represent the most commonly observed side effects of Semaglutide / Cyanocobalamin Injection, occurring in a substantial proportion of patients, particularly during the initial weeks of treatment or following dose escalations

2001 Jan;49(1):27-37

Ipamorelin Unlike BPC-157 and TB-500, which target local tissue repair, ipamorelin stimulates growth hormone (GH) release via the pituitary gland

Join me as I interview medical experts, renowned thought leaders and innovators of all types, helping you and bringing you information to achieve optimal performance and longevity